Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4(+) T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma

被引:339
作者
Durham, SR
Ying, S
Varney, VA
Jacobson, MR
Sudderick, RW
Mackay, IS
Kay, AB
Hamid, OA
机构
[1] ROYAL BROMPTON HOSP, DEPT ALLERGY & CLIN IMMUNOL, LONDON SW3 6LY, ENGLAND
[2] ROYAL BROMPTON HOSP, NOSE CLIN, LONDON SW3 6LY, ENGLAND
基金
英国医学研究理事会;
关键词
grass pollen immunotherapy; late nasal response; T lymphocyte; cytokine; eosinophil;
D O I
10.1016/S0091-6749(96)70205-1
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Grass pollen injection immunotherapy is effective in patients with summer hay fever, although efficacy must be balanced against possible side effects. The mechanism of immunotherapy is unknown but may be related to its ability to inhibit allergen-induced late responses, which are known to be characterized by infiltration of T lymphocytes, eosinophils, and cells with messenger RNA Sor so-called T-H2-type cytokines (IL-4 and IL-5). Objective: This study was designed to observe the effect of grass pollen immunotherapy on late nasal responses and associated cellular infiltration and cytokine mRNA expression. Methods: We performed local nasal provocation with grass pollen (and a control challenge) in 28 patients after a 12-month double-blind, placebo-controlled trial of immunotherapy. Nasal biopsy specimens were obtained at 24 hours and processed for immunohistology and in situ hybridization studies. Results: Grass pollen immunotherapy inhibited allergen-induced immediate (0 to 60 minutes) increases in sneezing (p < 0.02) and nasal blocking (p < 0.01) and late (0 to 24 hours) nasal symptoms (p < 0.05). Immunotherapy also inhibited the associated infiltration of the nasal mucosa by CD4(+) T lymphocytes and total (major basic protein-containing) and ''activated'' (cationic protein-secreting) eosinophils (all p = 0.03). There was a significant (p = 0.04) increase in cells expressing mRNA for interferon-gamma at 24 hours after allergen challenge, which correlated inversely with patients' seasonal symptoms (r = -0.65, p < 0.05) and medication requirements (r = -0.75, p < 0.02) during the pollen season. Conclusion: The results suggest that successful grass pollen immunotherapy for summer hay fever may act by inhibiting allergen-induced T lymphocyte and eosinophil recruitment and eosinophil activation in the target organ, possibly through a mechanism involving protective local increases in T-H1-type cells.
引用
收藏
页码:1356 / 1365
页数:10
相关论文
共 42 条
[1]  
[Anonymous], 1986, Br Med J (Clin Res Ed), V293, P948
[2]   DOUBLE-BLIND, PLACEBO-CONTROLLED IMMUNOTHERAPY WITH MIXED GRASS-POLLEN ALLERGOIDS .4. COMPARISON OF THE SAFETY AND EFFICACY OF 2 DOSAGES OF A HIGH-MOLECULAR-WEIGHT ALLERGOID [J].
BOUSQUET, J ;
HEJJAOUI, A ;
SOUSSANA, M ;
MICHEL, FB .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1990, 85 (02) :490-497
[3]   ALLERGIC RHINITIS TO RAGWEED POLLEN .2. MODULATION OF HISTAMINE-RELEASING FACTOR PRODUCTION BY SPECIFIC IMMUNOTHERAPY [J].
BRUNET, C ;
BEDARD, PM ;
LAVOIE, A ;
JOBIN, M ;
HEBERT, J .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1992, 89 (01) :87-94
[4]   ANTI-IL-5 MONOCLONAL-ANTIBODY INHIBITS ALLERGIC LATE PHASE BRONCHIAL EOSINOPHILIA IN GUINEA-PIGS - A THERAPEUTIC APPROACH [J].
CHAND, N ;
HARRISON, JE ;
ROONEY, S ;
PILLAR, J ;
JAKUBICKI, R ;
NOLAN, K ;
DIAMANTIS, W ;
SOFIA, RD .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 211 (01) :121-123
[5]  
CLUTTERBUCK EJ, 1989, BLOOD, V73, P1504
[6]   NASAL CHALLENGE WITH RAGWEED POLLEN IN HAY-FEVER PATIENTS - EFFECT OF IMMUNOTHERAPY [J].
CRETICOS, PS ;
ADKINSON, NF ;
KAGEYSOBOTKA, A ;
PROUD, D ;
MEIER, HL ;
NACLERIO, RM ;
LICHTENSTEIN, LM ;
NORMAN, PS .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (06) :2247-2253
[7]  
DELPRETE G, 1988, J IMMUNOL, V140, P4193
[9]  
DURHAM SR, 1992, J IMMUNOL, V148, P2390
[10]  
FANSLOW WC, 1991, J IMMUNOL, V147, P535